Review




Structured Review

Proteintech cd68 ab
Cd68 Ab, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 577 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd68 ab/product/Proteintech
Average 96 stars, based on 577 article reviews
cd68 ab - by Bioz Stars, 2026-03
96/100 stars

Images



Similar Products

96
Bio-Rad antibody ab 2892065
Antibody Ab 2892065, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody ab 2892065/product/Bio-Rad
Average 96 stars, based on 1 article reviews
antibody ab 2892065 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Bio-Rad mca1957 rrid ab 322219
Mca1957 Rrid Ab 322219, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mca1957 rrid ab 322219/product/Bio-Rad
Average 96 stars, based on 1 article reviews
mca1957 rrid ab 322219 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Proteintech cd68 ab
Cd68 Ab, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd68 ab/product/Proteintech
Average 96 stars, based on 1 article reviews
cd68 ab - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Boster Bio polyclonal antibody ab
Polyclonal Antibody Ab, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal antibody ab/product/Boster Bio
Average 93 stars, based on 1 article reviews
polyclonal antibody ab - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

96
Bio-Rad primary ab cd68
In vivo neuronal ABHD12 overexpression in sarmopathy mouse model reduces macrophage activation and rescues motor axon loss and neuropathy (A-A′) Representative images of AAV-mediated, neuron-specific expression of EGFP in the distal femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. EGFP expression reveals a population of blebbing axons. (B) Representative images of <t>CD68</t> immunostaining and EGFP-labeled axons in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. (C) Schematic for macrophage-axon association quantification. (D) Macrophage-axon distance quantification in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice ( n = 3 animals, each point replicates a counted axon). (E) Schematic of AAV-mediated, neuron-specific expression of EGFP or ABHD12-EGFP in 1-month-old Nmnat2 V98M/R232Q sarmopathy mice. (F and G) Representative images of CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (H) Representative images of Iba1 and CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of Abhd12 gene therapy. (I) Quantification of activated CD68 + and total Iba1+ macrophages in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (J) Percent axonal area/total nerve area for femoral nerve calculated at 3months (2months of AAV-mediated gene therapy with control ( n = 4) or Abhd12 IgG ( n = 5). (K) Average time suspended from an inverted screen (max. 120 s) for EGFP control ( n = 10) and ABHD12 gene therapy Nmnat2 V98M/R232Q ( n = 14) mice at 2 and 3 months of age. All data are presented as mean ± SEM. Statistical significance determined by Student’s unpaired t test or one-way ANOVA with multiple comparisons. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Primary Ab Cd68, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary ab cd68/product/Bio-Rad
Average 96 stars, based on 1 article reviews
primary ab cd68 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Bio-Rad mca341ga rrid ab 566872
In vivo neuronal ABHD12 overexpression in sarmopathy mouse model reduces macrophage activation and rescues motor axon loss and neuropathy (A-A′) Representative images of AAV-mediated, neuron-specific expression of EGFP in the distal femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. EGFP expression reveals a population of blebbing axons. (B) Representative images of <t>CD68</t> immunostaining and EGFP-labeled axons in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. (C) Schematic for macrophage-axon association quantification. (D) Macrophage-axon distance quantification in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice ( n = 3 animals, each point replicates a counted axon). (E) Schematic of AAV-mediated, neuron-specific expression of EGFP or ABHD12-EGFP in 1-month-old Nmnat2 V98M/R232Q sarmopathy mice. (F and G) Representative images of CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (H) Representative images of Iba1 and CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of Abhd12 gene therapy. (I) Quantification of activated CD68 + and total Iba1+ macrophages in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (J) Percent axonal area/total nerve area for femoral nerve calculated at 3months (2months of AAV-mediated gene therapy with control ( n = 4) or Abhd12 IgG ( n = 5). (K) Average time suspended from an inverted screen (max. 120 s) for EGFP control ( n = 10) and ABHD12 gene therapy Nmnat2 V98M/R232Q ( n = 14) mice at 2 and 3 months of age. All data are presented as mean ± SEM. Statistical significance determined by Student’s unpaired t test or one-way ANOVA with multiple comparisons. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Mca341ga Rrid Ab 566872, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mca341ga rrid ab 566872/product/Bio-Rad
Average 96 stars, based on 1 article reviews
mca341ga rrid ab 566872 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Elabscience Biotechnology cd68 antibody e-ab-22013
In vivo neuronal ABHD12 overexpression in sarmopathy mouse model reduces macrophage activation and rescues motor axon loss and neuropathy (A-A′) Representative images of AAV-mediated, neuron-specific expression of EGFP in the distal femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. EGFP expression reveals a population of blebbing axons. (B) Representative images of <t>CD68</t> immunostaining and EGFP-labeled axons in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. (C) Schematic for macrophage-axon association quantification. (D) Macrophage-axon distance quantification in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice ( n = 3 animals, each point replicates a counted axon). (E) Schematic of AAV-mediated, neuron-specific expression of EGFP or ABHD12-EGFP in 1-month-old Nmnat2 V98M/R232Q sarmopathy mice. (F and G) Representative images of CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (H) Representative images of Iba1 and CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of Abhd12 gene therapy. (I) Quantification of activated CD68 + and total Iba1+ macrophages in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (J) Percent axonal area/total nerve area for femoral nerve calculated at 3months (2months of AAV-mediated gene therapy with control ( n = 4) or Abhd12 IgG ( n = 5). (K) Average time suspended from an inverted screen (max. 120 s) for EGFP control ( n = 10) and ABHD12 gene therapy Nmnat2 V98M/R232Q ( n = 14) mice at 2 and 3 months of age. All data are presented as mean ± SEM. Statistical significance determined by Student’s unpaired t test or one-way ANOVA with multiple comparisons. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Cd68 Antibody E Ab 22013, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd68 antibody e-ab-22013/product/Elabscience Biotechnology
Average 90 stars, based on 1 article reviews
cd68 antibody e-ab-22013 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Proteintech 2 ig rrid ab 2881622
In vivo neuronal ABHD12 overexpression in sarmopathy mouse model reduces macrophage activation and rescues motor axon loss and neuropathy (A-A′) Representative images of AAV-mediated, neuron-specific expression of EGFP in the distal femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. EGFP expression reveals a population of blebbing axons. (B) Representative images of <t>CD68</t> immunostaining and EGFP-labeled axons in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. (C) Schematic for macrophage-axon association quantification. (D) Macrophage-axon distance quantification in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice ( n = 3 animals, each point replicates a counted axon). (E) Schematic of AAV-mediated, neuron-specific expression of EGFP or ABHD12-EGFP in 1-month-old Nmnat2 V98M/R232Q sarmopathy mice. (F and G) Representative images of CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (H) Representative images of Iba1 and CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of Abhd12 gene therapy. (I) Quantification of activated CD68 + and total Iba1+ macrophages in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (J) Percent axonal area/total nerve area for femoral nerve calculated at 3months (2months of AAV-mediated gene therapy with control ( n = 4) or Abhd12 IgG ( n = 5). (K) Average time suspended from an inverted screen (max. 120 s) for EGFP control ( n = 10) and ABHD12 gene therapy Nmnat2 V98M/R232Q ( n = 14) mice at 2 and 3 months of age. All data are presented as mean ± SEM. Statistical significance determined by Student’s unpaired t test or one-way ANOVA with multiple comparisons. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
2 Ig Rrid Ab 2881622, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2 ig rrid ab 2881622/product/Proteintech
Average 96 stars, based on 1 article reviews
2 ig rrid ab 2881622 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Proteintech mouse cd68 monoclonal ab
In vivo neuronal ABHD12 overexpression in sarmopathy mouse model reduces macrophage activation and rescues motor axon loss and neuropathy (A-A′) Representative images of AAV-mediated, neuron-specific expression of EGFP in the distal femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. EGFP expression reveals a population of blebbing axons. (B) Representative images of <t>CD68</t> immunostaining and EGFP-labeled axons in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. (C) Schematic for macrophage-axon association quantification. (D) Macrophage-axon distance quantification in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice ( n = 3 animals, each point replicates a counted axon). (E) Schematic of AAV-mediated, neuron-specific expression of EGFP or ABHD12-EGFP in 1-month-old Nmnat2 V98M/R232Q sarmopathy mice. (F and G) Representative images of CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (H) Representative images of Iba1 and CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of Abhd12 gene therapy. (I) Quantification of activated CD68 + and total Iba1+ macrophages in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (J) Percent axonal area/total nerve area for femoral nerve calculated at 3months (2months of AAV-mediated gene therapy with control ( n = 4) or Abhd12 IgG ( n = 5). (K) Average time suspended from an inverted screen (max. 120 s) for EGFP control ( n = 10) and ABHD12 gene therapy Nmnat2 V98M/R232Q ( n = 14) mice at 2 and 3 months of age. All data are presented as mean ± SEM. Statistical significance determined by Student’s unpaired t test or one-way ANOVA with multiple comparisons. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Mouse Cd68 Monoclonal Ab, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse cd68 monoclonal ab/product/Proteintech
Average 96 stars, based on 1 article reviews
mouse cd68 monoclonal ab - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

Image Search Results


In vivo neuronal ABHD12 overexpression in sarmopathy mouse model reduces macrophage activation and rescues motor axon loss and neuropathy (A-A′) Representative images of AAV-mediated, neuron-specific expression of EGFP in the distal femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. EGFP expression reveals a population of blebbing axons. (B) Representative images of CD68 immunostaining and EGFP-labeled axons in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. (C) Schematic for macrophage-axon association quantification. (D) Macrophage-axon distance quantification in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice ( n = 3 animals, each point replicates a counted axon). (E) Schematic of AAV-mediated, neuron-specific expression of EGFP or ABHD12-EGFP in 1-month-old Nmnat2 V98M/R232Q sarmopathy mice. (F and G) Representative images of CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (H) Representative images of Iba1 and CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of Abhd12 gene therapy. (I) Quantification of activated CD68 + and total Iba1+ macrophages in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (J) Percent axonal area/total nerve area for femoral nerve calculated at 3months (2months of AAV-mediated gene therapy with control ( n = 4) or Abhd12 IgG ( n = 5). (K) Average time suspended from an inverted screen (max. 120 s) for EGFP control ( n = 10) and ABHD12 gene therapy Nmnat2 V98M/R232Q ( n = 14) mice at 2 and 3 months of age. All data are presented as mean ± SEM. Statistical significance determined by Student’s unpaired t test or one-way ANOVA with multiple comparisons. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Journal: iScience

Article Title: Suppressing phagocyte activation by overexpressing the phosphatidylserine lipase ABHD12 preserves sarmopathic nerves

doi: 10.1016/j.isci.2025.112626

Figure Lengend Snippet: In vivo neuronal ABHD12 overexpression in sarmopathy mouse model reduces macrophage activation and rescues motor axon loss and neuropathy (A-A′) Representative images of AAV-mediated, neuron-specific expression of EGFP in the distal femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. EGFP expression reveals a population of blebbing axons. (B) Representative images of CD68 immunostaining and EGFP-labeled axons in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice. (C) Schematic for macrophage-axon association quantification. (D) Macrophage-axon distance quantification in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice ( n = 3 animals, each point replicates a counted axon). (E) Schematic of AAV-mediated, neuron-specific expression of EGFP or ABHD12-EGFP in 1-month-old Nmnat2 V98M/R232Q sarmopathy mice. (F and G) Representative images of CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (H) Representative images of Iba1 and CD68 immunostaining in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of Abhd12 gene therapy. (I) Quantification of activated CD68 + and total Iba1+ macrophages in femoral nerve of 3-month-old Nmnat2 V98M/R232Q sarmopathy mice after two months of control (EGFP) or Abhd12 gene therapy. (J) Percent axonal area/total nerve area for femoral nerve calculated at 3months (2months of AAV-mediated gene therapy with control ( n = 4) or Abhd12 IgG ( n = 5). (K) Average time suspended from an inverted screen (max. 120 s) for EGFP control ( n = 10) and ABHD12 gene therapy Nmnat2 V98M/R232Q ( n = 14) mice at 2 and 3 months of age. All data are presented as mean ± SEM. Statistical significance determined by Student’s unpaired t test or one-way ANOVA with multiple comparisons. ns: not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Article Snippet: Six μm–thick sections of sciatic nerves were prepared on a cryostat (Leica CM1860), mounted onto slides, and processed as previously described using the following antibodies: (a) for activated macrophages , primary Ab CD68 (1:100, Bio-Rad, MCA1957GA) and secondary Ab anti-rat Cy3 (1:500, Jackson Immunoresearch, 112-165-143); (b) for total macrophages , primary Ab Iba-1 (1:500, Wako Chemicals, 019–19741) and secondary Ab anti-rabbit Alexa Fluor 488 (1:500, Invitrogen, A11034); Sciatic nerves were imaged with the Leica DMI 4000B confocal microscope at ×20 magnification.

Techniques: In Vivo, Over Expression, Activation Assay, Expressing, Immunostaining, Labeling, Control